Emmanuel Nony

USPTO Granted Patents = 29 (Patent Applications = 5)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 18)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 119(Granted Patents)

Company Filing History:

16 out of 85

Laboratoire Francais Du Fractionnement Et Des Biotechnologies

Institut National De La Sante Et De La Recherche Medicale

patents

where one patent can have more than one assignee

Years Active: 2009-2021

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11015221 - Markers of immune response (2021-05-25),

2. 10884002 - Sialylated fetuin-A as a marker of immunotherapy efficacy (2021-01-05),

3. 10364425 - Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units (2019-07-30),

4. 10344272 - Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units (2019-07-09),

5. 10190166 - Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy (2019-01-29),

6. 10101341 - Biomarkers of immunotherapy efficacy (2018-10-16),

7. 10081683 - Monoclonal antibodies with enhanced ADCC function (2018-09-25),

8. 9879089 - Use of ADCC-optimized antibodies for treating low-responder patients (2018-01-30),

9. 9868770 - Recombinant Der P 2 expressed in Pichia Pastoris as a 'natural-like' allergen for immunotherapy and diagnostic purposes (2018-01-16),

10. 9822185 - Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa (2017-11-21),

11. 9718890 - Monoclonal antibodies with enhanced ADCC function (2017-08-01),

12. 9718889 - Monoclonal antibodies with enhanced ADCC function (2017-08-01),

13. 9708409 - Monoclonal antibodies with enhanced ADCC function (2017-07-18),

14. 9187568 - [object Object] (2015-11-17),

15. 9109020 - Use of ADCC-optimized antibodies for treating weak patients (2015-08-18),

Title: Inventor Emmanuel Nony

Introduction: Emmanuel Nony is a renowned inventor based in Antony, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Emmanuel Nony holds several patents in various technological domains, showcasing his continuous commitment to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Emmanuel Nony has established himself as a visionary inventor, with a keen focus on developing solutions that have a tangible impact on society.

Collaborations: Throughout his career, Emmanuel Nony has collaborated with leading tech companies, research institutions, and universities to further his inventions and bring them to market, solidifying his reputation as a forward-thinker in the industry.

Conclusion: Emmanuel Nony's passion for innovation and his relentless drive to create have cemented his status as a prominent figure in the world of inventors, with his work continuing to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.